Hacker News with Generative AI: Clinical Trials

Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson's (nature.com)
More than 100 clinical trials put stem cells for regenerative medicine to the test. It’s a turning point for a field beset with ethical and political controversy.
The case for clinical trial abundance (ifp.org)
In 2014, the first SGLT2 inhibitor, dapagliflozin, was approved for patients with Type II diabetes for the control of blood glucose levels. Since then, the list of indications for this class of molecules has expanded to include kidney disease (2021) and heart failure (2020) in non-diabetics, both important sources of morbidity and mortality. Despite being an already developed drug with safety data, these repurposings took seven and six years, respectively.
Promising early data in triple negative breast cancer (statnews.com)
New data suggests researchers may have found one of their most promising candidates yet for the next generation in immunotherapy drugs — bispecific antibodies targeting two key proteins in cancer, PD1 or PD-L1 and VEGF.A small early trial on one such bispecific compound was presented by researchers working with BioNTech at the San Antonio Breast Cancer Symposium on Tuesday. The bispecific compound, called BNT-327, had positive results in patients with triple negative breast cancer.
Progress and prospects of mRNA-based drugs in pre-clinical/clinical applications (nature.com)
In the last decade, messenger ribonucleic acid (mRNA)-based drugs have gained great interest in both immunotherapy and non-immunogenic applications.
Psilocybin bests SSRI for major depression in first long-term comparison (medscape.com)
Rwanda to receive experimental vaccines to combat Marburg outbreak (statnews.com)
Experimental vaccines and therapeutics to combat the deadly Marburg virus will begin arriving this weekend in Rwanda, where they will be used in clinical trials expected to begin soon, a U.S. government official confirmed on Friday.
mRNA cancer vaccine shows potential for advanced stage cancer patients (kcl.ac.uk)
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers.
Gilead's twiceyearly shot cut HIV infections by 96% in trial (cnbc.com)
Epilepsy drug shows promise in reducing obstructive sleep apnea symptoms (ajmc.com)
Sulthiame, an epilepsy drug sold under the brand name Ospolot in Europe, appeared to reduce symptoms of obstructive sleep apnea (OSA) in a late-breaking clinical trial presented at the European Respiratory Society (ERS) Congress 2024.
World-first lung cancer vaccine trials launched across seven countries (theguardian.com)
World-first mRNA lung cancer vaccine trials launched in seven countries (theguardian.com)
New HIV Prevention Drug Shows 100% Efficacy in Clinical Trial (sciencealert.com)
Gilead shot prevents all HIV cases in trial (bloomberg.com)
Psychedelics are challenging the standard of randomized controlled trials (theatlantic.com)
Trial results for new lung cancer drug are 'off the charts' (theguardian.com)
Personalised melanoma mRNA cancer trial in stage 3 (theguardian.com)
The emotional trial of clinical trials: like online dating with death risk (jakeseliger.com)
Infected blood scandal: Children were used as 'guinea pigs' in clinical trials (bbc.com)